Clinical Trial Details
EORTC-55892
Back to Clinical Trials Database
Phase II study of high dose Epirubicin in patients with advanced ovarian carcinoma
Trial Status | All trial activities ended |
---|---|
Dates |
Date of activation: 15-May-1990 Date Step1 close: 26-May-1994 |
Data management at EORTC | Yes |
Design |
Phase 2 Randomized open label |
Targeted Sample size | EORTC Groups: 42 |
Treatment | |
Study Staff | |
Type of cancer | |
Participating groups | |
Protocol summary | http://clinicaltrials.gov/study/ |
NCT number |